Nihat Şengeze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nihat Şengeze has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Semih Giray
Departmant of Neurology, Gaziantep University Hospital, Gaziantep, Turkey
4 shared publications Semih Giray
Department of Neurology, Gaziantep University Hospital, Gaziantep, Turkey
3 shared publications- Alper Eren
Department of Neurology, Faculty of Medicine, Ataturk University, Erzurum, Türkiye
2 shared publications Burak Gürel
Department of Neurology, Isparta City Hospital, Isparta, Turkey
2 shared publications- Ekin Öykü Baylam Yirmibeş
Süleyman Demirel Üniversitesi Tıp Fakültesi
2 shared publications İsmail Zi̇hni̇
SÜLEYMAN DEMİREL ÜNİVERSİTESİ, TIP FAKÜLTES
2 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Turkish Society of Cerebrovascular Diseases in Turkish Journal of Cerebrovascular Diseases
- p. 1-6
Efficacy and safety of endovascular treatments in large middle cerebral artery infarcts
Background: Mechanical thrombectomy is recommended for patients with middle cerebral artery (MCA) segment 1 (M1) occlusion within 6 hours of symptom onset by American Stroke Association. This study aimed to demonstrate the safety of endovascular treatments in MCA M1 infarcts and compare the safety and effectiveness of direct thrombectomy and intravenous tissue plasminogen activator (iv-tPA) bridging therapy before mechanical thrombectomy. Methods: A retrospective, observational study was conducted on patients with large MCA infarction on brain imaging. Patients who received endovascular treatment were included in the endovascular therapy (EVT) group, while who received only iv-tPA were included in the iv-tPA group. Patients who underwent direct mechanical thrombectomy or bridging therapy were identified. Clinical outcomes at 3 months and symptomatic intracerebral hemorrhage (SIH) rates were compared between the groups. Results: The EVT group showed good clinical outcomes (modified Rankin score [mRS] ≤ 2) at 3 months was significantly higher than the iv-tPA group, while; SIH rates were similar. There was no statistically significant difference in terms of good clinical outcomes between direct mechanical thrombectomy and bridging therapy groups. But, SIH rates were significantly higher in the direct mechanical thrombectomy group. Conclusion: Our study showed that for large MCA infarct, EVT provides better clinical outcomes than iv-tPA alone, and that direct mechanical thrombectomy may be an effective choice for patients who are unsuitable for iv-tPA. Additionally, our findings also contribute to the literature indicating that bridging therapy is a safe option.
- 8 July 2026
- Published by Turkish Society of Cerebrovascular Diseases in Turkish Journal of Cerebrovascular Diseases
- p. 1-6
Open AccessEfficacy and safety of endovascular treatments in large middle cerebral artery infarcts
Background: Mechanical thrombectomy is recommended for patients with middle cerebral artery (MCA) segment 1 (M1) occlusion within 6 hours of symptom onset by American Stroke Association. This study aimed to demonstrate the safety of endovascular treatments in MCA M1 infarcts and compare the safety and effectiveness of direct thrombectomy and intravenous tissue plasminogen activator (iv-tPA) bridging therapy before mechanical thrombectomy. Methods: A retrospective, observational study was conducted on patients with large MCA infarction on brain imaging. Patients who received endovascular treatment were included in the endovascular therapy (EVT) group, while who received only iv-tPA were included in the iv-tPA group. Patients who underwent direct mechanical thrombectomy or bridging therapy were identified. Clinical outcomes at 3 months and symptomatic intracerebral hemorrhage (SIH) rates were compared between the groups. Results: The EVT group showed good clinical outcomes (modified Rankin score [mRS] ≤ 2) at 3 months was significantly higher than the iv-tPA group, while; SIH rates were similar. There was no statistically significant difference in terms of good clinical outcomes between direct mechanical thrombectomy and bridging therapy groups. But, SIH rates were significantly higher in the direct mechanical thrombectomy group. Conclusion: Our study showed that for large MCA infarct, EVT provides better clinical outcomes than iv-tPA alone, and that direct mechanical thrombectomy may be an effective choice for patients who are unsuitable for iv-tPA. Additionally, our findings also contribute to the literature indicating that bridging therapy is a safe option.
- Open Access
- 30 April 2026
- Published by Turkish Society of Cerebrovascular Diseases in Turkish Journal of Cerebrovascular Diseases
- Vol. 32 (1) , 59-62
2026 AHA/ASA guideline for the early management of acute ischemic stroke: Updates with implications for clinical practice
Recent advances in acute ischemic stroke management have led to significant updates in clinical practice guidelines. The 2026 AHA/ASA guideline introduces important changes in prehospital organization, reperfusion strategies, and early in-hospital management. System-level improvements, including mobile stroke units and regional stroke networks, are emphasized to reduce treatment delays and optimize patient outcomes. In reperfusion therapy, updated recommendations expand the use of intravenous thrombolysis and mechanical thrombectomy, with greater reliance on imaging-based patient selection, particularly in extended time windows. The guideline also highlights the importance of rapid decision-making, streamlined workflows, and avoidance of unnecessary delays in treatment initiation. These updates reflect a shift toward individualized, time-sensitive, and system-oriented stroke care. This review summarizes the key changes and discusses their implications for daily clinical practice.
- 30 April 2026
- Published by Turkish Society of Cerebrovascular Diseases in Turkish Journal of Cerebrovascular Diseases
- Vol. 32 (1) , 59-62
Open Access2026 AHA/ASA guideline for the early management of acute ischemic stroke: Updates with implications for clinical practice
Recent advances in acute ischemic stroke management have led to significant updates in clinical practice guidelines. The 2026 AHA/ASA guideline introduces important changes in prehospital organization, reperfusion strategies, and early in-hospital management. System-level improvements, including mobile stroke units and regional stroke networks, are emphasized to reduce treatment delays and optimize patient outcomes. In reperfusion therapy, updated recommendations expand the use of intravenous thrombolysis and mechanical thrombectomy, with greater reliance on imaging-based patient selection, particularly in extended time windows. The guideline also highlights the importance of rapid decision-making, streamlined workflows, and avoidance of unnecessary delays in treatment initiation. These updates reflect a shift toward individualized, time-sensitive, and system-oriented stroke care. This review summarizes the key changes and discusses their implications for daily clinical practice.
- Open Access
- 15 March 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (6) , 108295
The frequency of carotid web in cryptogenic stroke and its association with stroke risk factors
- 15 March 2025
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 34 (6) , 108295
Open AccessThe frequency of carotid web in cryptogenic stroke and its association with stroke risk factors
- Open Access
- 21 June 2024
- Published by Saglik Bilimleri Universitesi in İzmir Tıp Fakültesi Dergisi
- Vol. 3 (2) , 70-76
Detection of Possible Trigger Nutrition Factors in Migraine Patients with Alternating Diet Model
Aim: The aim of this study is to determine the effects of diet programs on the severity and duration of migraines and the number of attacks by administering cheese, caffeine, and chocolate-restricted diet programs to patients. Material and Methods: The migraine patients included in the study were given three different (chocolate-free, cheese-free, caffeine-free) dietary recommendations and were given a chart in which they could record their migraine attacks. The dietary recommendations were administered separately every two weeks. The chart filled out by the patients was collected through face-to-face interviews at the end of the total 6 weeks. Results: The study determined a decrease in the duration, severity, and number of migraine attacks in the period of a diet free from cheese, caffeine, and chocolate. Except for the decrease in the number of attacks on the caffeine-free diet, all the decreases are statistically significant. Conclusion: This study shows that using a cheese-free, chocolate-free, or caffeine-free diet in managing migraine patients may improve the quality of life, and the need for drug treatment may decrease.
- 21 June 2024
- Published by Saglik Bilimleri Universitesi in İzmir Tıp Fakültesi Dergisi
- Vol. 3 (2) , 70-76
Open AccessDetection of Possible Trigger Nutrition Factors in Migraine Patients with Alternating Diet Model
Aim: The aim of this study is to determine the effects of diet programs on the severity and duration of migraines and the number of attacks by administering cheese, caffeine, and chocolate-restricted diet programs to patients. Material and Methods: The migraine patients included in the study were given three different (chocolate-free, cheese-free, caffeine-free) dietary recommendations and were given a chart in which they could record their migraine attacks. The dietary recommendations were administered separately every two weeks. The chart filled out by the patients was collected through face-to-face interviews at the end of the total 6 weeks. Results: The study determined a decrease in the duration, severity, and number of migraine attacks in the period of a diet free from cheese, caffeine, and chocolate. Except for the decrease in the number of attacks on the caffeine-free diet, all the decreases are statistically significant. Conclusion: This study shows that using a cheese-free, chocolate-free, or caffeine-free diet in managing migraine patients may improve the quality of life, and the need for drug treatment may decrease.
- 26 October 2023
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 134 (11) , 1250-1255
Efficacy and safety of intravenous thrombolytic therapy in patients over eighty years
Introduction: Intravenous thrombolytic therapy (IVTT) is licensed for patients under 80 years in many countries. In this study, we aimed to demonstrate functional results and complication rates of IVTT in patients over eighty years and whether there is a difference in efficacy and safety between low dose and standard dose recombinant tissue plasminogen activator (rTPA).Methods: A retrospective observational study of patients over eighty who admitted to Suleyman Demirel University Faculty of Medicine Hospital between August 2016 and April 2021 and to Isparta City Hospital between April 2017 and April 2021 and diagnosed with acute ischemic stroke were conducted. Third month modified rankin scores (mRS) and mortality rates of patients and hemorrhagic transformations were determined.Results: There were 29 patients in IVTT group and 25 patients in non-IVTT group. By the third month, it was observed that functional independence (mRS 0-2) ratio was increased more in IVTT group, but it wasn't statistically significant (p: 0.087). In mortality and symptomatic intracerebral hemorrhage rates, there wasn't statistically significant diffirence between IVTT and non-IVTT groups and low dose and standard dose rTPA groups by the third month.Conclusion: The efficacy and complication rates of IVTT in patients over 80 years were found similar to not receive IVTT. These results support the safety of IVTT in patients over 80 years. In low or standard dose rTPA preference, we observed that there wasnt' statistically significance in efficacy and safety. We believe that these results will be supported by studies with larger number of patients.
- 26 October 2023
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 134 (11) , 1250-1255
Efficacy and safety of intravenous thrombolytic therapy in patients over eighty years
Introduction: Intravenous thrombolytic therapy (IVTT) is licensed for patients under 80 years in many countries. In this study, we aimed to demonstrate functional results and complication rates of IVTT in patients over eighty years and whether there is a difference in efficacy and safety between low dose and standard dose recombinant tissue plasminogen activator (rTPA).Methods: A retrospective observational study of patients over eighty who admitted to Suleyman Demirel University Faculty of Medicine Hospital between August 2016 and April 2021 and to Isparta City Hospital between April 2017 and April 2021 and diagnosed with acute ischemic stroke were conducted. Third month modified rankin scores (mRS) and mortality rates of patients and hemorrhagic transformations were determined.Results: There were 29 patients in IVTT group and 25 patients in non-IVTT group. By the third month, it was observed that functional independence (mRS 0-2) ratio was increased more in IVTT group, but it wasn't statistically significant (p: 0.087). In mortality and symptomatic intracerebral hemorrhage rates, there wasn't statistically significant diffirence between IVTT and non-IVTT groups and low dose and standard dose rTPA groups by the third month.Conclusion: The efficacy and complication rates of IVTT in patients over 80 years were found similar to not receive IVTT. These results support the safety of IVTT in patients over 80 years. In low or standard dose rTPA preference, we observed that there wasnt' statistically significance in efficacy and safety. We believe that these results will be supported by studies with larger number of patients.
- Open Access
- 30 June 2022
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 29 (2) , 149-151
COVID-19 MANAGEMENT IN SULEYMAN DEMIREL UNIVERSITY HOSPITAL: THE SECOND YEAR CHRONOLOGY OF A PANDEMIC
Pandemi henüz bitmiş değildir, pandeminin ikinci yılı özellikle delta ve omicron varyantlarının, özellikle ikinci yarısı da normalleşme kararlarının etkisi altında geçti. Toplumsal uyumun bu süreçteki tartışmasız tek doğru olduğu gerçeği hem Türkiye hem de Dünya için değişmedi.
- 30 June 2022
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 29 (2) , 149-151
Open AccessCOVID-19 MANAGEMENT IN SULEYMAN DEMIREL UNIVERSITY HOSPITAL: THE SECOND YEAR CHRONOLOGY OF A PANDEMIC
Pandemi henüz bitmiş değildir, pandeminin ikinci yılı özellikle delta ve omicron varyantlarının, özellikle ikinci yarısı da normalleşme kararlarının etkisi altında geçti. Toplumsal uyumun bu süreçteki tartışmasız tek doğru olduğu gerçeği hem Türkiye hem de Dünya için değişmedi.
- 6 March 2022
- Published by SAGE Publications in Angiology
- Vol. 73 (9) , 835-842
Predictors of Symptomatic Hemorrhage After Endovascular Treatment for Anterior Circulation Occlusions: Turkish Endovascular Stroke Registry
We evaluated the predictive factors of symptomatic intracranial hemorrhage (SICH) in endovascular treatment of stroke. We included 975 ischemic stroke patients with anterior circulation occlusion. Patients that had hemorrhage and an increase of ≥4 points in their National Institutes of Health Stroke Scale (NIHSS) after the treatment were considered as SICH. The mean age of patients was 65.2±13.1 years and 469 (48.1%) were women. The median NIHSS was 16 (13–18) and Alberta Stroke Program Early CT 9 (8–10). In 420 patients (43.1%), modified Rankin Scale was favorable (0–2) and mortality was observed in 234 (24%) patients at the end of the third month. Patients with high diastolic blood pressure ( P<.05) had significantly higher SICH. SICH was significantly higher in those with high NIHSS scores ( P<.001), high blood glucose ( P<.001), and leukocyte count at admission ( P<.05). Diabetes mellitus (DM) (OR 1.90; P<.001), NIHSS (OR 1.07; P<.05), adjuvant intra-arterial thrombolytic therapy (IA-rtPA) (OR, 1.60; P<.05), and puncture-recanalization time (OR 1.01; P<.05) were independent factors of SICH. Higher baseline NIHSS score, longer procedure time, multiple thrombectomy maneuvers, administration of IA-rtPA, and the history of DM are independent predictors of SICH in anterior circulation occlusion.
- 6 March 2022
- Published by SAGE Publications in Angiology
- Vol. 73 (9) , 835-842
Predictors of Symptomatic Hemorrhage After Endovascular Treatment for Anterior Circulation Occlusions: Turkish Endovascular Stroke Registry
We evaluated the predictive factors of symptomatic intracranial hemorrhage (SICH) in endovascular treatment of stroke. We included 975 ischemic stroke patients with anterior circulation occlusion. Patients that had hemorrhage and an increase of ≥4 points in their National Institutes of Health Stroke Scale (NIHSS) after the treatment were considered as SICH. The mean age of patients was 65.2±13.1 years and 469 (48.1%) were women. The median NIHSS was 16 (13–18) and Alberta Stroke Program Early CT 9 (8–10). In 420 patients (43.1%), modified Rankin Scale was favorable (0–2) and mortality was observed in 234 (24%) patients at the end of the third month. Patients with high diastolic blood pressure ( P<.05) had significantly higher SICH. SICH was significantly higher in those with high NIHSS scores ( P<.001), high blood glucose ( P<.001), and leukocyte count at admission ( P<.05). Diabetes mellitus (DM) (OR 1.90; P<.001), NIHSS (OR 1.07; P<.05), adjuvant intra-arterial thrombolytic therapy (IA-rtPA) (OR, 1.60; P<.05), and puncture-recanalization time (OR 1.01; P<.05) were independent factors of SICH. Higher baseline NIHSS score, longer procedure time, multiple thrombectomy maneuvers, administration of IA-rtPA, and the history of DM are independent predictors of SICH in anterior circulation occlusion.
- Open Access
- 1 February 2022
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 54 (1) , 17-21
Does the Stent Retriever Placement in the Division of Middle Cerebral Artery Affect the Recanalization Success in M1 Occlusions?
Objective: The location of arterial occlusions can be predictive in the prognosis and endovascular treatment of acute stroke patients. We aimed to determine if the location of the stent retriever being on the superior or inferior division of the middle cerebral artery has an effect on the success and clinical outcomes of recanalization in middle cerebral artery M1 occlusion. Materials and Methods: Data were generated for the period from May 2015 to January 2019. Divisions of middle cerebral artery were assigned to the 2 groups as superior and inferior divisions according to the anatomical classification. The dominant trunk of the artery was assessed on the last angiogram image. Results: We eventually included 81/90 patients (mean age: 62 ± 13.5; 63% [51/81] female; mean National Institutes of Health Stroke Scale rating: 16.3 ± 3.6) treated with thrombectomy. The branches of the middle cerebral artery were as follows: 40 (49.4%) co-dominant, 22 (27.2%) inferior, and 19 (23.5%) superior division dominant. The stent retriever was placed in the dominant trunk in 22/41(53.7%) cases at first pass. When stent retriever was placed in the dominant middle cerebral artery trunk, the rate of successful recanalization was very high with the first pass of thrombectomy (P < .001). Conclusion: Stent retriever placement within the superior or inferior middle cerebral artery trunk does not have an effect on the success rate of recanalization; however, its placement in the dominant trunk can increase the chance of complete recanalization to be early. Cite this article as: Sengeze N, Gıray S. Does the stent retriever placement in the division of middle cerebral artery affect the recanalization success in M1 occlusions? Eurasian J Med 2022;54(1):17-21.
- 1 February 2022
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 54 (1) , 17-21
Open AccessDoes the Stent Retriever Placement in the Division of Middle Cerebral Artery Affect the Recanalization Success in M1 Occlusions?
Objective: The location of arterial occlusions can be predictive in the prognosis and endovascular treatment of acute stroke patients. We aimed to determine if the location of the stent retriever being on the superior or inferior division of the middle cerebral artery has an effect on the success and clinical outcomes of recanalization in middle cerebral artery M1 occlusion. Materials and Methods: Data were generated for the period from May 2015 to January 2019. Divisions of middle cerebral artery were assigned to the 2 groups as superior and inferior divisions according to the anatomical classification. The dominant trunk of the artery was assessed on the last angiogram image. Results: We eventually included 81/90 patients (mean age: 62 ± 13.5; 63% [51/81] female; mean National Institutes of Health Stroke Scale rating: 16.3 ± 3.6) treated with thrombectomy. The branches of the middle cerebral artery were as follows: 40 (49.4%) co-dominant, 22 (27.2%) inferior, and 19 (23.5%) superior division dominant. The stent retriever was placed in the dominant trunk in 22/41(53.7%) cases at first pass. When stent retriever was placed in the dominant middle cerebral artery trunk, the rate of successful recanalization was very high with the first pass of thrombectomy (P < .001). Conclusion: Stent retriever placement within the superior or inferior middle cerebral artery trunk does not have an effect on the success rate of recanalization; however, its placement in the dominant trunk can increase the chance of complete recanalization to be early. Cite this article as: Sengeze N, Gıray S. Does the stent retriever placement in the division of middle cerebral artery affect the recanalization success in M1 occlusions? Eurasian J Med 2022;54(1):17-21.
- Open Access
- 4 October 2021
- Published by Turk Noroloji Dernegi in Turkish Journal Of Neurology
- Vol. 27 (3) , 306-310
The Relationship Between the Type of Parkinson’s Disease and Entrapment Neuropathy in the Upper Extremities
- 4 October 2021
- Published by Turk Noroloji Dernegi in Turkish Journal Of Neurology
- Vol. 27 (3) , 306-310
Open AccessThe Relationship Between the Type of Parkinson’s Disease and Entrapment Neuropathy in the Upper Extremities
- 1 August 2021
- Published by Galenos Yayinevi in CAM and Sakura Medical Journal
- Vol. 1 (2) , 69-75
Is the Anatomical Type of the Arcus Aorta an Effective Factor for the Success of Endovascular Therapy?
- 1 August 2021
- Published by Galenos Yayinevi in CAM and Sakura Medical Journal
- Vol. 1 (2) , 69-75
Is the Anatomical Type of the Arcus Aorta an Effective Factor for the Success of Endovascular Therapy?